Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-18-001762
Filing Date
2018-03-09
Accepted
2018-03-09 16:03:44
Documents
70
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K s109195_10k.htm 10-K 1201988
2 EXHIBIT 21.01 s109195_ex21-01.htm EX-21.01 2919
3 EXHIBIT 23.1 s109195_ex23-01.htm EX-23.1 4282
4 EXHIBIT 31.01 s109195_ex31-01.htm EX-31.01 10022
5 EXHIBIT 31.02 s109195_ex31-02.htm EX-31.02 10049
6 EXHIBIT 32.01 s109195_ex32-01.htm EX-32.01 5413
  Complete submission text file 0001615774-18-001762.txt   4464102

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE tnxp-20171231.xml EX-101.INS 700048
8 XBRL SCHEMA FILE tnxp-20171231.xsd EX-101.SCH 48023
9 XBRL CALCULATION FILE tnxp-20171231_cal.xml EX-101.CAL 52443
10 XBRL DEFINITION FILE tnxp-20171231_def.xml EX-101.DEF 153357
11 XBRL LABEL FILE tnxp-20171231_lab.xml EX-101.LAB 367055
12 XBRL PRESENTATION FILE tnxp-20171231_pre.xml EX-101.PRE 267029
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 18680069
SIC: 2834 Pharmaceutical Preparations